Showing 1-50 of 913 stocks
| Number | Ticker | Industry | Market Cap | Last Price | Change % | Volume |
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | Biotechnology: Pharmaceutical Preparations | $818.6B | $1,104.44 | -2.49% | 2.4M |
| 2 | JNJJohnson & Johnson | Biotechnology: Pharmaceutical Preparations | $546.9B | $225.52 | -2.64% | 4.2M |
| 3 | ABBVAbbVie Inc. | Biotechnology: Pharmaceutical Preparations | $358.5B | $217.78 | -0.34% | 2.7M |
| 4 | UNHUnitedHealth Group | Medical Specialities | $333.1B | $379.88 | -0.46% | 3.9M |
| 5 | AZNAstraZeneca PLC | Biotechnology: Pharmaceutical Preparations | $316.4B | $185.28 | -0.51% | 1.1M |
| 6 | NVSNovartis AG | Biotechnology: Pharmaceutical Preparations | $278.6B | $150.56 | -0.63% | 1.2M |
| 7 | MRKMerck & Company Inc. (new) | Biotechnology: Pharmaceutical Preparations | $268.7B | $118.37 | -1.45% | 5.5M |
| 8 | PMPhilip Morris International Inc | Medicinal Chemicals and Botanical Products | $266.5B | $177.34 | -0.67% | 2.2M |
| 9 | NVONovo Nordisk A/S | Biotechnology: Biological Products (No Diagnostic Substances) | $197.4B | $45.62 | -0.18% | 8.6M |
| 10 | AMGNAmgen Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $183.1B | $336.45 | -0.24% | 998.8K |
| 11 | GILDGilead Sciences Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $168.6B | $134.06 | -1.63% | 3.9M |
| 12 | ISRGIntuitive Surgical Inc. | Medical/Dental Instruments | $166.8B | $424.34 | +0.21% | 1.6M |
| 13 | ABTAbbott Laboratories | Medical/Dental Instruments | $152.9B | $85.76 | -0.56% | 6.5M |
| 14 | PFEPfizer Inc. | Biotechnology: Pharmaceutical Preparations | $147.6B | $26.12 | -0.19% | 16.9M |
| 15 | BTIBritish American Tobacco Industries p.l.c. ADR | Medicinal Chemicals and Botanical Products | $140.8B | $61.73 | -1.88% | 3.0M |
| 16 | MDTMedtronic plc. | Biotechnology: Electromedical & Electrotherapeutic Apparatus | $131.9B | $74.07 | -2.06% | 10.5M |
| 17 | BMYBristol-Myers Squibb Company | Biotechnology: Pharmaceutical Preparations | $115.3B | $56.96 | -0.15% | 7.4M |
| 18 | SYKStryker Corporation | Medical/Dental Instruments | $109.3B | $307.77 | +0.25% | 2.0M |
| 19 | GSKGSK plc (Each representing two) | Biotechnology: Pharmaceutical Preparations | $108.7B | $50.64 | -1.59% | 2.2M |
| 20 | MOAltria Group Inc. | Medicinal Chemicals and Botanical Products | $107.8B | $69.61 | -3.25% | 5.9M |
| 21 | HCAHCA Healthcare Inc. | Hospital/Nursing Management | $105.5B | $377.73 | -2.13% | 795.9K |
| 22 | SNYSanofi ADS | Biotechnology: Pharmaceutical Preparations | $101.6B | $43.76 | -1.54% | 2.0M |
| 23 | MCKMcKesson Corporation | Other Pharmaceuticals | $99.7B | $741.33 | -2.06% | 786.2K |
| 24 | BSXBoston Scientific Corporation | Medical/Dental Instruments | $93.4B | $48.38 | -1.60% | 24.4M |
| 25 | ELVElevance Health Inc. | Medical Specialities | $85.7B | $394.30 | +0.87% | 988.3K |
| 26 | CIThe Cigna Group | Medical Specialities | $79.0B | $277.52 | -2.63% | 781.3K |
| 27 | MMM3M Company | Medical/Dental Instruments | $76.7B | $153.18 | +0.26% | 1.7M |
| 28 | REGNRegeneron Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $73.2B | $614.57 | -1.10% | 968.1K |
| 29 | CORCencora Inc. | Other Pharmaceuticals | $68.5B | $269.14 | +0.63% | 1.6M |
| 30 | TAKTakeda Pharmaceutical Company Limited (each representing 1/2 of a share of) | Biotechnology: Pharmaceutical Preparations | $52.4B | $15.96 | -1.30% | 1.7M |
| 31 | BDXBecton Dickinson and Company | Medical/Dental Instruments | $51.5B | $147.23 | -0.25% | 1.4M |
| 32 | EWEdwards Lifesciences Corporation | Industrial Specialties | $50.2B | $86.34 | +0.53% | 4.0M |
| 33 | CAHCardinal Health Inc. | Other Pharmaceuticals | $45.7B | $196.54 | -1.48% | 1.3M |
| 34 | IDXXIDEXX Laboratories Inc. | Biotechnology: In Vitro & In Vivo Diagnostic Substances | $43.6B | $566.88 | +0.17% | 399.7K |
| 35 | ARGXargenx SE | Biotechnology: Biological Products (No Diagnostic Substances) | $42.9B | $832.97 | -1.22% | 149.7K |
| 36 | TEVATeva Pharmaceutical Industries Limited | Biotechnology: Pharmaceutical Preparations | $39.9B | $35.28 | +2.32% | 3.7M |
| 37 | ALNYAlnylam Pharmaceuticals Inc. | Biotechnology: Pharmaceutical Preparations | $39.0B | $301.31 | -1.46% | 637.9K |
| 38 | MDLNMedline Inc. Class A Common Stock | Medical/Dental Instruments | $37.4B | $36.71 | +0.00% | 8.2M |
| 39 | ALCAlcon Inc. | Ophthalmic Goods | $32.4B | $66.33 | +0.93% | 2.2M |
| 40 | ONCBeiGene Ltd. American Depositary Shares | Biotechnology: Pharmaceutical Preparations | $31.4B | $288.34 | +0.00% | 102.3K |
| 41 | ZTSZoetis Inc. | Biotechnology: Pharmaceutical Preparations | $31.2B | $77.75 | -0.90% | 4.1M |
| 42 | RVMDRevolution Medicines Inc. | Biotechnology: Biological Products (No Diagnostic Substances) | $30.1B | $156.65 | +1.44% | 3.4M |
| 43 | RMDResMed Inc. | Medical/Dental Instruments | $29.4B | $191.22 | -6.35% | 2.0M |
| 44 | NTRANatera Inc. | Medical Specialities | $29.1B | $222.50 | +4.24% | 1.5M |
| 45 | IQVIQVIA Holdings Inc. | Biotechnology: Commercial Physical & Biological Resarch | $28.6B | $181.77 | +0.75% | 1.3M |
| 46 | DXCMDexCom Inc. | Medical/Dental Instruments | $27.8B | $73.44 | +1.68% | 3.9M |
| 47 | BIIBBiogen Inc. | Biotechnology: Pharmaceutical Preparations | $27.3B | $196.27 | -0.35% | 548.8K |
| 48 | PHGKoninklijke Philips N.V. NY Registry Shares | Medical Electronics | $25.3B | $26.45 | -0.17% | 734.0K |
| 49 | UTHRUnited Therapeutics Corporation | Biotechnology: Pharmaceutical Preparations | $25.1B | $554.88 | -1.35% | 305.2K |
| 50 | BNTXBioNTech SE | Biotechnology: Biological Products (No Diagnostic Substances) | $24.2B | $96.29 | +2.92% | 881.2K |
This page provides a comprehensive list of stocks in the Health Care sector. The data includes market capitalization, current prices, price changes, trading volume, and industry classification.
Disclaimer: The information provided on this page is for informational purposes only and should not be considered as financial advice. Stock prices and market data are subject to change. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.